| Pharmaceutical active ingredients: |
| Hyaluronate Sodium |
| Available forms, composition and doses of Hialudorf: |
| N / A |
| Hialudorf medical category: |
| Human:Drugs acting on musculo-skeletal systemDrugs acting on the genito-urinary systemEar preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesTopical antihistamines, antipruritics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D03AX05 - Hyaluronic AcidM09AX01 - Hyaluronic AcidR01AX09 - Hyaluronic AcidS01KA01 - Hyaluronic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PharmaDorf |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Hiact-P | Dimethicone; Fructooligosaccharides; Pancreatin | Dyota Numandis Pharmaceuticals |
| HI-Alarzin | Tolnaftate | Unidentified Pharmaceutical Company |
| HI-Alazin | Tolnaftate | Unidentified Pharmaceutical Company |
| Hialid | Hyaluronate Sodium | Santen Pharmaceutical; Agencia Tai Tong Hong; Croma Medic; Ferron; Greater Pharma; Hong Kong Medical Supplies; IDS Group; JDH Pharmaceutical; Leader Pharmaceutical & Cosmetic; Oui Heng Import |
| Hializan | Oxazolam | Sanofi-Aventis |
| Hiamine | Ethylenediamine Dihydroiodide | Unidentified Pharmaceutical Company |
| Hi-A-Vita | Vitamin A | Unidentified Pharmaceutical Company |
| HIB Merieux | Haemophilus Influenzae conjugate Vaccine (Diphtheria Toxoid conjugate) | Sanofi-Aventis |
| Hib Titer | Haemophilus Influenzae Type B (Strain PBCC197) Oligosaccharide, conjugated to diphtheria CRM197 protein | Wyeth |
| Hi-B-100 Super Potency Timed Release | Choline Bitartrate; Folic Acid; Inositol; Vitamin B1; Vitamin B12; Vitamin B2; Vitamin B3 (Nicotinamide); Vitamin B5 (Calcium D-Pantothenate); Vitamin B6 (Pyridoxine Hydrochloride); Vitamin H (Biotin) | Country Life Vitamins |